Company Analysis

Vyome Holdings, Inc. (HIND)

Nasdaq: HIND · Pharmaceutical Preparations · San Clemente, CA · filing with the SEC since 2008
Grade2.7
◀ Past 1.4● Present 1.8▶ Future 4.2
1 est.

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

53 patents granted to the 5 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Vyome Holdings, Inc.’s names, not what it holds today.

Patents granted
53
52 utility, 1 reissue, 1976 to Dec 31, 2025
Granted in 2025
4
Against 3 in 2024 and 4 in 2023
Applications published
80
7 of them in 2025
Names they are printed under
5
a former name, a subsidiary
By yearGrantedApplications published
'10'12'13'14'15'16'17'18'19'20'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Medical technology14
Pharmaceuticals1
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name5 counted
Obalon Therapeutics, Inc. a former name
US, as the owner printed on each patent
32 granted
14 published
Obalon Therapeutics, Inc. a former name
named as the applicant on its applications, in US
0 granted
39 published
RESHAPE LIFESCIENCES INC. a former name
US, as the owner printed on each patent
19 granted
3 published
RESHAPE LIFESCIENCES, INC. a former name
named as the applicant on its applications, in US
0 granted
19 published
VYOME THERAPEUTICS LIMITED a subsidiary
IN, as the owner printed on each patent
2 granted
5 published
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Oct 14, 202512,440,358Pressure control system for intragastric deviceMedical technologyRESHAPE LIFESCIENCES INC.
Jul 8, 202512,350,179Intragastric deviceMedical technologyRESHAPE LIFESCIENCES INC.
Jun 17, 202512,329,972High-frequency low duty cycle patterns for nerual regulationMedical technologyRESHAPE LIFESCIENCES INC.
May 27, 202512,311,174Simultaneous multi-site vagus nerve neuromodulation for improved glycemic control system and methodsMedical technologyRESHAPE LIFESCIENCES INC.
Oct 1, 202412,102,547Intragastric volume-occupying device and method for fabricating sameMedical technologyRESHAPE LIFESCIENCES INC.
Sep 17, 202412,090,075Intragastric deviceMedical technologyRESHAPE LIFESCIENCES INC.
May 7, 202411,974,934Intragastric deviceMedical technologyRESHAPE LIFESCIENCES INC.
Nov 21, 202311,819,433Pressure control system for intragastric deviceMedical technologyRESHAPE LIFESCIENCES INC.
Oct 10, 202311,779,482Intragastric deviceMedical technologyRESHAPE LIFESCIENCES INC.
Aug 29, 202311,737,899Intragastric deviceMedical technologyRESHAPE LIFESCIENCES INC.
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Dec 18, 20252025/0381404HIGH-FREQUENCY LOW DUTY CYCLE PATTERNS FOR NEURAL REGULATIONMedical technologyRESHAPE LIFESCIENCES, INC.
Sep 25, 20252025/0295920SIMULTANEOUS MULTI-SITE VAGUS NERVE NEUROMODULATION FOR IMPROVED GLYCEMIC CONTROL SYSTEM AND METHODSMedical technologyRESHAPE LIFESCIENCES INC.
Aug 28, 20252025/0269182INTERMITTENT DUAL VAGUS NEUROMODULATION TREATMENT FOR IMPROVED GLYCEMIC CONTROL IN TYPE 2 DIABETESMedical technologyRESHAPE LIFESCIENCES, INC.
Aug 14, 20252025/0256105NEUROMODULATION OF TWO OR MORE NEURONAL TARGETS IN TREATMENT OF A MEDICAL CONDITIONMedical technologyRESHAPE LIFESCIENCES INC.
Aug 7, 20252025/0249248VAGUS NERVE NEUROMODULATION FOR THE TREATMENT OF THE HYPOGLYCEMIC STATEMedical technologyRESHAPE LIFESCIENCES, INC.
Jul 24, 20252025/0235338INTRAGASTRIC DEVICEMedical technologyRESHAPE LIFESCIENCES, INC.
Jul 17, 20252025/0228684INTRAGASTRIC VOLUME-OCCUPYING DEVICE AND METHOD FOR FABRICATING SAMEMedical technologyRESHAPE LIFESCIENCES, INC.
Sep 26, 20242024/0315860PRESSURE CONTROL SYSTEM FOR INTRAGASTRIC DEVICEMedical technologyRESHAPE LIFESCIENCES, INC. · patent 12,440,358 granted from it
May 9, 20242024/0148531SYSTEMS AND METHODS FOR DETERMINING FAILURE OF INTRAGASTRIC DEVICESMedical technologyRESHAPE LIFESCIENCES, INC.
Jan 18, 20242024/0016635INTRAGASTRIC DEVICEMedical technologyRESHAPE LIFESCIENCES, INC. · patent 11,974,934 granted from it
What it applied for, 2024 to 2025: Medical technology 10.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton HIND · research, not advice